"58160-830-34" National Drug Code (NDC)

Cervarix 1 SYRINGE in 1 CARTON (58160-830-34) > .5 mL in 1 SYRINGE (58160-830-05)
(GlaxoSmithKline Biologicals SA)

NDC Code58160-830-34
Package Description1 SYRINGE in 1 CARTON (58160-830-34) > .5 mL in 1 SYRINGE (58160-830-05)
Product NDC58160-830
Product Type NameVACCINE
Proprietary NameCervarix
Non-Proprietary NameHuman Papillomavirus Bivalent (types 16 And 18) Vaccine, Recombinant
Dosage FormINJECTION, SUSPENSION
UsageINTRAMUSCULAR
Start Marketing Date20091016
Marketing Category NameBLA
Application NumberBLA125259
ManufacturerGlaxoSmithKline Biologicals SA
Substance NameHUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN
Strength20; 20
Strength Unitug/.5mL; ug/.5mL

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/58160-830-34